Friday, July 10, 2026

pharma · Body weight management · Acromegaly

Currus Biologics Pty

Camurus Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Body weight management, Acromegaly, gastroenteropancreatic neuroendocrine tumors. NovaPharmaNews links 3 clinical program(

Melbourne, AU HQ
2021 Founded
11 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2021
Employees
11
Programs
3
Drugs
14
Patents
0
Clinical program

HS-24-787

Phase 1 · other · Body weight management

HS-24-787 for Body weight management is a Phase 1 program (other) at Camurus Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code HS-24-787

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Camurus Pty Ltd
Phase
Phase 1
Modality
other
Indication
Body weight management
Status
active
Trials
1